H2-receptor antagonists in the treatment of peptic ulcer.
D000380:Agranulocytosis / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D004381:Duodenal Ulcer / Q000188:drug therapy; D005750:Gastric Juice / Q000378:metabolism; D006146:Guanidines / Q000009:adverse effects / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D008785:Metiamide / Q000009:adverse effects / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D011955:Receptors, Drug / Q000187:drug effects; D013276:Stomach Ulcer / Q000188:drug therapy
D006146:Guanidines; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D011955:Receptors, Drug; D008785:Metiamide